Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Deep neuromuscular blockade and nociception-guided anesthesia during laparoscopic abdominal surgery
NL-OMON52953Phase 4Terminated
- Sponsor
- Leiden University Medical Center
- Start
- Dec 2020
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of rocuronium and Sugammadex, sponsored by Leiden University Medical Center. Primary endpoint: Mean arterial pressure at 30 minutes after installation of the pneumoperitoneum. Started Dec 2020; status: terminated.
02
Drugs
rocuroniumSugammadex
Beyond the preview
Go deeper on NL-OMON52953.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON52953.